Omnicell, Inc. carries a market capitalization of 1.86B, placing it among publicly traded companies globally. Its enterprise value stands at 1.47B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.86B |
| Enterprise Value | 1.47B |
Omnicell, Inc. currently has 45.48M shares outstanding.
| Shares Outstanding | 45.48M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Omnicell, Inc. trades at a trailing price-to-earnings ratio of 74.58. The price-to-sales ratio is 1.24, and the price-to-book ratio stands at 3.84.
| PE Ratio | 74.58 |
| PS Ratio | 1.24 |
| PB Ratio | 3.84 |
| P/TBV Ratio | 5.06 |
| P/FCF Ratio | 7.17 |
| P/OCF Ratio | 9.78 |
On an enterprise value basis, Omnicell, Inc. trades at an EV/EBITDA multiple of 12.38 and an EV/FCF ratio of 6.88. The EV/Sales ratio of 1.20 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 43.78 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.20 |
| EV / EBITDA | 12.38 |
| EV / EBIT | 43.78 |
| EV / FCF | 6.88 |
Omnicell, Inc. maintains a current ratio of 1.50, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.50 |
| Quick Ratio | 1.04 |
| Debt / Equity | 16.09 |
| Debt / EBITDA | 1.70 |
| Interest Coverage | N/A |
Omnicell, Inc. posts a return on equity of 5.29 and a return on invested capital of 1.17.
| Return on Equity (ROE) | 5.29 |
| Return on Assets (ROA) | 0.98 |
| Return on Invested Capital (ROIC) | 1.17 |
| Return on Capital Employed (ROCE) | 3.00 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 7.27 |
Over the trailing twelve months, Omnicell, Inc. has paid 17.33M in income taxes, reflecting an effective tax rate of 45.89.
| Income Tax | 17.33M |
| Effective Tax Rate | 45.89 |
Omnicell, Inc.'s stock has gained approximately 44.89362% over the past 52 weeks. The 50-day moving average sits at 42.59, while the 200-day moving average is 40.02.
| Beta (5Y) | N/A |
| 52-Week Price Change | 44.89362% |
| 50-Day Moving Average | 42.59 |
| 200-Day Moving Average | 40.02 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Omnicell, Inc. generated 1.23B in revenue and converted that into 20.43M in net income, yielding earnings per share of 0.44. EBITDA reached 118.93M, while operating income came in at 33.63M.
| Revenue | 1.23B |
| Gross Profit | 532.87M |
| Operating Income | 33.63M |
| Pretax Income | 37.76M |
| Net Income | 20.43M |
| EBITDA | 118.93M |
| EBIT | 33.63M |
| Earnings Per Share (EPS) | 0.44 |
Omnicell, Inc. holds 253.64M in cash and equivalents against 202.18M in total debt, resulting in a net debt position of -71.32M. Total book value stands at 396.36M, with working capital of 239.25M providing operational flexibility.
| Cash & Cash Equivalents | 253.64M |
| Total Debt | 202.18M |
| Net Debt | -71.32M |
| Equity (Book Value) | 396.36M |
| Book Value Per Share | 8.68 |
| Working Capital | 239.25M |
Omnicell, Inc. produced 155.88M in operating cash flow over the past twelve months. After subtracting -58.06M in capital expenditures, free cash flow totaled 97.82M - equivalent to 2.14 per share.
| Operating Cash Flow | 155.88M |
| Capital Expenditures | -58.06M |
| Free Cash Flow | 97.82M |
| FCF Per Share | 2.14 |
Omnicell, Inc. operates with a gross margin of 43.50, reflecting its pricing power and cost economics. The operating margin of 2.75 and net profit margin of 1.67 provide insight into operational efficiency.
| Gross Margin | 43.50 |
| Operating Margin | 2.75 |
| Pretax Margin | 3.08 |
| Profit Margin | 1.67 |
| EBITDA Margin | 9.71 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 14.43 |
| FCF Yield | 13.95 |
Omnicell, Inc. posts an Altman Z-Score of 3.30, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.30 |